IL169148A0 - Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination - Google Patents

Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination

Info

Publication number
IL169148A0
IL169148A0 IL169148A IL16914805A IL169148A0 IL 169148 A0 IL169148 A0 IL 169148A0 IL 169148 A IL169148 A IL 169148A IL 16914805 A IL16914805 A IL 16914805A IL 169148 A0 IL169148 A0 IL 169148A0
Authority
IL
Israel
Prior art keywords
diuretic
methods
dosage forms
ace inhibitor
heart attacks
Prior art date
Application number
IL169148A
Original Assignee
King Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Inc filed Critical King Pharmaceuticals Inc
Publication of IL169148A0 publication Critical patent/IL169148A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL169148A 2002-12-16 2005-06-14 Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination IL169148A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43384502P 2002-12-16 2002-12-16
PCT/US2003/041056 WO2004056360A1 (en) 2002-12-16 2003-12-16 Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination

Publications (1)

Publication Number Publication Date
IL169148A0 true IL169148A0 (en) 2007-07-04

Family

ID=32681973

Family Applications (1)

Application Number Title Priority Date Filing Date
IL169148A IL169148A0 (en) 2002-12-16 2005-06-14 Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination

Country Status (10)

Country Link
EP (1) EP1589965A1 (en)
JP (1) JP2006511567A (en)
KR (1) KR20050102080A (en)
CN (1) CN1731996A (en)
AU (1) AU2003303208A1 (en)
BR (1) BR0317326A (en)
CA (1) CA2508269A1 (en)
IL (1) IL169148A0 (en)
MX (1) MXPA05006399A (en)
WO (1) WO2004056360A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282519B2 (en) 2003-08-28 2007-10-16 Nitromed, Inc. Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
EP1734931A2 (en) 2004-03-24 2006-12-27 Actavis Group Formulations of ramipril
US7396829B2 (en) 2005-02-24 2008-07-08 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
US9769354B2 (en) 2005-03-24 2017-09-19 Kofax, Inc. Systems and methods of processing scanned data
US9767354B2 (en) 2009-02-10 2017-09-19 Kofax, Inc. Global geographic information retrieval, validation, and normalization
US9576272B2 (en) 2009-02-10 2017-02-21 Kofax, Inc. Systems, methods and computer program products for determining document validity
US9165188B2 (en) 2012-01-12 2015-10-20 Kofax, Inc. Systems and methods for mobile image capture and processing
US10146795B2 (en) 2012-01-12 2018-12-04 Kofax, Inc. Systems and methods for mobile image capture and processing
US9355312B2 (en) 2013-03-13 2016-05-31 Kofax, Inc. Systems and methods for classifying objects in digital images captured using mobile devices
JP2016517587A (en) 2013-03-13 2016-06-16 コファックス， インコーポレイテッド Classification of objects in digital images captured using mobile devices
US9208536B2 (en) 2013-09-27 2015-12-08 Kofax, Inc. Systems and methods for three dimensional geometric reconstruction of captured image data
US20140316841A1 (en) 2013-04-23 2014-10-23 Kofax, Inc. Location-based workflows and services
DE202014011407U1 (en) 2013-05-03 2020-04-20 Kofax, Inc. Systems for recognizing and classifying objects in videos captured by mobile devices
JP2016538783A (en) 2013-11-15 2016-12-08 コファックス， インコーポレイテッド System and method for generating a composite image of a long document using mobile video data
US9760788B2 (en) 2014-10-30 2017-09-12 Kofax, Inc. Mobile document detection and orientation based on reference object characteristics
US10242285B2 (en) 2015-07-20 2019-03-26 Kofax, Inc. Iterative recognition-guided thresholding and data extraction
US9779296B1 (en) 2016-04-01 2017-10-03 Kofax, Inc. Content-based detection and three dimensional geometric reconstruction of objects in image and video data
US11062176B2 (en) 2017-11-30 2021-07-13 Kofax, Inc. Object detection and image cropping using a multi-detector approach
CN109524075A (en) * 2018-10-22 2019-03-26 平安医疗健康管理股份有限公司 Drug expenditure risk of exceeding criterion control method and device based on data processing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3055904A (en) * 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1731996A (en) 2006-02-08
JP2006511567A (en) 2006-04-06
CA2508269A1 (en) 2004-07-08
BR0317326A (en) 2005-11-16
WO2004056360A1 (en) 2004-07-08
AU2003303208A1 (en) 2004-07-14
KR20050102080A (en) 2005-10-25
MXPA05006399A (en) 2006-01-27
EP1589965A1 (en) 2005-11-02

Similar Documents

Publication Publication Date Title
IL169148A0 (en) Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination
PL372814A1 (en) Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
AU2003298514A8 (en) Methods and compositions using cholinesterase inhibitors
AU2003271923A8 (en) Facilitating and authenticating transactions
EP1541585A4 (en) Cxcr4 antagonist and use thereof
IL166377A0 (en) Vrgfr-2 and vgefr-3 inhibitory and anthranylamidpyrimidines
IL175260A0 (en) Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
AU2003287519A8 (en) Microprocessor including a first level cache and a second level cache having different cache line sizes
AU2003220205A8 (en) Ethanol-diesel fuel composition and methods thereof
IL169112A0 (en) Phosphonooxy quinazoline derivatives and their pharmaceuitical use
AU2003278703A8 (en) Energy harvesting circuits and associated methods
GB0206227D0 (en) Bore-lining and drilling
AU2003270312A8 (en) Capacity management and timing
GB2396707B (en) Facilitating and authenticating transactions
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
EP1599904A4 (en) Lateral lubistor structure and method
SG106160A1 (en) Steel stud with openings and edge formations and method
AU2003256526A8 (en) Arrangements and methods for treating a subject
GB0225012D0 (en) Desmear and texturing method
AU2003251513A8 (en) Rsk inhibitors and therapeutic uses thereof
AU2003291508A8 (en) Barrier coatings and methods in discharge lamps
GB2388916B (en) Improvements in and relating to piezo-electric elements
AU2003222258A8 (en) Inhibitors for use in hemostasis
AU2003238948A8 (en) Caspase-1 inhibitors and methods for their use
AU2003282583A8 (en) Via-less electronic structures and methods